Process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
A process for producing microencapsulates comprising an active component such as creatine encapsulated within a polymerized hydrolyzed whey protein matrix is described. The method comprises the steps of providing a suspension of hydrolyzed whey protein and an active component in a carboxylic ester, treating the suspension to generate droplets of the suspension, and immediately curing the droplets by immersion in a basic curing solution, wherein the ester in the suspension reacts with the basic curing solution to release a salt that polymerizes the hydrolyzed whey protein encapsulating the active component in the presence of black pepper extract, glycerol, phosphate and optionally, astaxanthin and alpha lipoic acid.
1. A process for producing microencapsulates comprising an active component encapsulated within a polymerised hydrolysed protein matrix, the method comprising the steps of
(a) providing a suspension comprising hydrolysed protein, an active component, and a liquid carboxylic ester,
(b) extruding the suspension through a nozzle, thereby generating droplets of the suspension, and
(c) immediately curing the droplets by immersion in a basic curing solution, wherein the liquid carboxylic ester in the suspension reacts with the basic curing solution to release a salt that polymerises the hydrolysed protein, thereby producing the microencapsulates.
2. The process of claim 1 , wherein the hydrolysed protein is hydrolysed whey protein.
3. The process of claim 1 , wherein the suspension additionally comprises pepper extract, wherein polymerisation of the hydrolysed protein encapsulates the active component and the pepper extract.
4. The process of claim 1 , wherein the step of providing the suspension comprises mixing the active component, the hydrolysed protein, an organic carboxylic acid, and an alcohol, wherein the organic carboxylic acid and the alcohol react to form the liquid carboxylic ester.
5. The process of claim 1 , wherein the basic curing solution comprises 0.01M-1.0M glycerol.
6. The process of claim 1 , wherein the step of extruding the suspension to generate droplets employs a dual extrusion nozzle having a central nozzle and an outer nozzle, wherein the suspension is extruded through the central nozzle and a coating formulation comprising hydrolysed protein and a carboxylic ester is extruded through the outer nozzle to provide droplets having a core comprising the suspension and a coating comprising the coating formulation.
7. The process of claim 6 , wherein the suspension is an emulsion and comprises an oil-soluble component.
8. The process of claim 7 , wherein the oil-soluble component comprises astaxanthin that is optionally dissolved in a fatty acid.
9. The process of claim 1 , wherein the active component is a pharmaceutically active agent.
10. The process of claim 1 , wherein the active component comprises a creatine moiety, L-glutamine, L-leucine, beta-alanine, or a branched chain amino acid.